Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2006
03/09/2006US20060052594 New corticosteroids
03/09/2006US20060052457 Use of ppar alpha agonists for the treatment of vascular and renal diseases
03/09/2006US20060052455 Composition for preventing treating the xepression of clinical symptom in disease caused by mitochondrial dysfunction
03/09/2006US20060052450 Use of l-carnitine for the treatment of cardiovascular diseases
03/09/2006US20060052447 Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositios comprising them and processes for the preparation of them
03/09/2006US20060052437 Combination of an hmg-coa reductase inhibitor and a nitrate ester
03/09/2006US20060052419 Use of pyridly amides as inhibitors of angiogenesis
03/09/2006US20060052415 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form
03/09/2006US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist
03/09/2006US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
03/09/2006US20060052398 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
03/09/2006US20060052397 Compounds for trearment of cardiovascular disorders and hypotensive agents
03/09/2006US20060052389 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
03/09/2006US20060052376 Carboxamides
03/09/2006US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding
03/09/2006US20060052351 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides and oxidative stress
03/09/2006US20060052333 Method of treating arrhythmias
03/09/2006US20060052332 1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-carboxamides; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart
03/09/2006US20060052329 Regulation of human P2Y1-like G protein-coupled receptor
03/09/2006US20060052314 Pharmaceutical combination
03/09/2006US20060052313 Selective dipeptide inhibitors of kallikrein
03/09/2006US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring
03/09/2006US20060051877 Fibronectin biopolymer marker indicative of insulin resistance
03/09/2006US20060051867 Cell growth
03/09/2006US20060051438 Herbal medicaments for the treatment of neurocerebrovascular disorders
03/09/2006US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs
03/09/2006US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells
03/09/2006US20060051344 Antibody and utilization of the same
03/09/2006US20060051318 Medical composition for treating ischemic cardiac failure
03/09/2006US20060049269 Generation of therapeutic microfoam
03/09/2006DE102004042607A1 Substituierte Phenylaminothiazole und ihre Verwendung Substituted Phenylaminothiazole and their use
03/09/2006DE10019195B4 Reversible Immortalisierung Reversible immortalization
03/09/2006CA2577613A1 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof
03/09/2006CA2576839A1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
03/09/2006CA2576827A1 Vegf inhibition
03/09/2006CA2567377A1 Inhibition of atherosclerosis by diindolylmethane analogs
03/08/2006EP1632574A1 Fibroblast growth factor homologs
03/08/2006EP1632488A1 Cyclic tertiary amine compound
03/08/2006EP1632470A2 Calcium receptor active molecules
03/08/2006EP1632259A2 Anti-angiogene compositions and methods of use
03/08/2006EP1632241A1 Preventive and/or remedy for diseases accompanied by tissue destruction
03/08/2006EP1632224A1 Spill resistant pharmaceutical compositions
03/08/2006EP1631565A1 Piperazine-alkyl-ureido derivatives
03/08/2006EP1631299A2 Methods and compositions to treat myocardial conditions
03/08/2006EP1631270A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases
03/08/2006EP1523483A4 Amino-bicyclic pyrazinones and pyridinones as coagulation serine protease inhibitors
03/08/2006EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics
03/08/2006EP1465627B1 DOSING REGIMEN FOR PPAR−GAMMA ACTIVATORS
03/08/2006EP1455602B1 Modified methionine rich food products and process for their manufacture
03/08/2006EP1451303A4 Detection of haematopoietic stem cells and progeny and uses thereof
03/08/2006EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
03/08/2006EP1438341B1 Antibody stimulating il-1ra production
03/08/2006EP1429689A4 Rational drug therapy device and methods
03/08/2006EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/08/2006EP1365761B1 Therapeutic combination of amlodipine and benazepril
03/08/2006EP1353926B1 Mikanolide derivatives, their preparation and therapeutic uses
03/08/2006EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
03/08/2006EP1347756B1 Controlled release of anti-arrhythmic agents from a biodegradable hydrogel for local application to the heart
03/08/2006EP1346221B1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor
03/08/2006EP1328285B1 Oral preparation containing seaweed for reduction of plaque and calculus
03/08/2006EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
03/08/2006EP1294389B1 Therapeutical use of sophora flavescens or sophora subprostrata extracts
03/08/2006EP1278770B1 Human wingless-like gene
03/08/2006EP1276722B1 Naphthamidine urokinase inhibitors
03/08/2006EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases
03/08/2006EP1087781B1 Dietary supplement for supporting cerebrovascular tone
03/08/2006EP1071430B1 Treatment of iatrogenic and age-related hypertension with vitamin b6 derivatives and pharmaceutical compositions useful therein
03/08/2006EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
03/08/2006EP0948327B1 Antidiabetic agents
03/08/2006CN1745080A 1,3-dihydroimidazole fused-ring compound
03/08/2006CN1745078A Pyridine derivatives useful for inhibiting sodium/calcium exchange system
03/08/2006CN1745074A 5-HT receptor ligands and uses thereof
03/08/2006CN1745071A Novel ethylenediamine derivatives
03/08/2006CN1744954A Biological control of nanoparticles
03/08/2006CN1744920A Novel compositions magnetic particles covered with gem-bisphosphonate derivatives
03/08/2006CN1744911A NOGO,CASPR,F3,NB-3 for treatment of injury and disease to the central nervous system
03/08/2006CN1744893A Method for treating ischemic stroke with melatonin
03/08/2006CN1744891A Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of EDHF function
03/08/2006CN1744890A Labeled macrophage scavenger receptor antagonists for imaging cardiovacular diseases
03/08/2006CN1743316A 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use
03/08/2006CN1743315A 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use
03/08/2006CN1743314A 2-substituted-4,4,5,5-tetramethyl-1-oxyimidazoline, and its synthesis and use
03/08/2006CN1743302A Arylpiperazines having 5-hydroxyl-typtamine activity
03/08/2006CN1743006A New use of MAPK inhibitor and its composition thereof
03/08/2006CN1743005A New use of PI3-K inhibitor and its composition
03/08/2006CN1742999A Method for preparing nano freeze-dried powder comprising human-body calcitonin gene relative peptide and product made therefrom and use thereof
03/08/2006CN1742997A Mimetics of interleukin-8 and use of them in the prevention, treatment, diagnosis of a disease
03/08/2006CN1742987A Guanxin preparation for treating coronary disease and new preparing method
03/08/2006CN1742986A Guanxi-shengmai preparation and new preparing method
03/08/2006CN1742984A Medicine copmosition, its preparing method and quality control method
03/08/2006CN1742981A Chinese medicine injecta preparing method for treating syncope
03/08/2006CN1742958A Medicated pillow for treating cardiovascular and cerebrovascular disease
03/08/2006CN1742949A Chinese medicine composition with functions of reducing blood-pressure, reducing-fat, anti-dizzy and calming wind, its preparing method and use
03/08/2006CN1742948A Chinese medicine preparation for treating syncope and preparing method thereof
03/08/2006CN1742937A Chinese medicine preparation for treating cardiovascular and cerebrovascular and preparing method
03/08/2006CN1742931A Instant preparation of radix polygonatic officinais and cassia tora and preparing process thereof
03/08/2006CN1742924A Yellow Chinese yam total saponin injecta and preparing method thereof
03/08/2006CN1742915A Ointment for diminishing piles
03/08/2006CN1742902A Chinese medicinal pills for treating coronary heart disease
03/08/2006CN1742900A Chinese medicine composition for treating apoplexy